Precision Cancer Care. Connected Across India.
IPAC brings together oncology expertise, molecular science, clinical research, clinical trials, innovation and patient access to build a more connected cancer ecosystem for India.
Cancer care is becoming more complex. The ecosystem must become more connected.
Modern oncology increasingly requires clinical, pathological, molecular, imaging, research and patient-level information to work together. IPAC is designed as the connective layer between these communities.
Precision
Integrate biomarkers, pathology, imaging and clinical context to support individualized cancer care.
Research
Enable multicenter research, registries, real-world evidence and translational oncology.
Access
Connect patients and clinicians to expertise, diagnostics, trials and coordinated pathways.
Innovation
Accelerate responsible use of AI, liquid biopsy, digital health and new oncology technologies.
One alliance. Multiple pathways.
IPAC is designed to connect care, evidence generation, clinical research, education and innovation rather than operate as a single service line.
From molecular profile to multidisciplinary discussion.
Molecular diagnostics, tumor boards, expert referrals, second opinions, treatment planning and patient navigation.
Turning clinical questions into evidence.
Investigator-initiated studies, multicenter research, real-world evidence, registries and translational programs.
Bringing research opportunities closer to patients.
Trial discovery, eligibility assessment, investigator review, site referral and a future-ready trial network.
Building the next generation of oncology capability.
AI, digital oncology, liquid biopsy, early detection, investigator training, masterclasses and fellowships.
Making precision oncology more accessible.
IPAC facilitates connections across the clinical and molecular components needed for increasingly complex cancer care.
Molecular Diagnostics
Support access to biomarker and molecular testing pathways relevant to precision oncology.
Explore pathway →Molecular Tumor Boards
Facilitate structured multidisciplinary review of complex molecular and clinical cases.
Learn more →Patient Navigation
Help patients understand, coordinate and move through complex cancer-care pathways.
Start a journey →Turning clinical questions into evidence.
IPAC is structured to support researchers and institutions across the full research lifecycle.
Investigator-Initiated Research
Support scientifically meaningful oncology questions from concept and protocol development through execution.
Multicenter Research
Connect institutions and investigators to enable collaborative studies across India.
Real-World Evidence & Registries
Build structured datasets and disease- or biomarker-specific registries for evidence generation.
Bringing clinical trials closer to patients.
Design the network around responsible identification, eligibility assessment and connection to qualified trial sites and investigators.
Future IPAC trial pathway
Where oncology meets innovation.
IPAC can serve as a collaboration platform for emerging technologies that have the potential to improve cancer prevention, diagnosis, treatment and research.
AI in Oncology
Responsible AI and clinical decision-support applications.
Liquid Biopsy
Biomarker and early-detection research pathways.
Digital Oncology
Connected data, remote monitoring and patient-support technologies.
Precision Diagnostics
Integrating molecular, imaging and clinical information.
A national network. One shared mission.
Membership can bring together clinical, academic, research, technology, diagnostics, industry and patient-support communities.
Clinical Partners
Oncologists, surgeons, pathologists, radiologists and allied specialists.
Institutional Partners
Hospitals, cancer centers, universities and research institutions.
Research Partners
Academic investigators, CROs and research organizations.
Innovation Partners
AI, digital health, diagnostics and biotechnology organizations.
Industry Partners
Pharmaceutical and biotechnology organizations.
Patient & Community Partners
Patient advocacy and cancer-support organizations.
Build the evidence before publishing the numbers.
Impact metrics should be populated only after they are verified and approved for public use.
Built on scientific integrity.
IPAC should earn trust through transparent governance, ethical research practices, responsible technology and clear separation between information, navigation and clinical decision-making.
The future of cancer care will be connected.
IPAC is building a network that connects precision oncology, research, innovation, expertise and patient access across India.
Built for collaboration, evidence and translation.
IPAC is designed to work alongside focused scientific initiatives, research alliances and technology partners across the oncology ecosystem.
Precision Diagnostics
Connect molecular diagnostics, biomarkers and clinical interpretation to support precision oncology pathways.
Translational Science
Bridge laboratory innovation, clinical research and real-world implementation across cancer care.
Collaborative Alliances
Enable structured collaboration with specialist research initiatives, academic networks and innovation partners.
LIBRA reference ecosystem →